Tuberculosis Vaccine Market Global Enhancements and Growth Outlook and Forecast from 2021 to 2028

-
Tuberculosis Vaccines
Tuberculosis Vaccine

Market Dynamics for Tuberculosis Vaccines

Tuberculosis is the leading cause of death due to an infectious disease in the world. According to the World Health Organization (WHO) factsheet 2018 on tuberculosis (TB), 10.4 million individuals became infected with the disease in 2016, and 1.7 million died from it in the same year. More than 95% of tuberculosis deaths occur in low- and middle-income countries. Deaths from tuberculosis also include 0.4 million HIV-infected persons. Such a large number of patients worldwide confirms the magnitude of the disease and the critical need for vaccines all around the world. As a result, the introduction of a Tuberculosis Vaccine Market would generate significant income, propelling market expansion.

According to a global assessment on tuberculosis vaccination published in 2018, TB costs the global economy approximately US$ 21 billion per year. Another significant impetus for the Tuberculosis Vaccine Market would be the current complex treatment regime and the resistance that TB has created to this drug regime. In order to suppress the infection, TB patients must take more than 2-3 medications for a period of 6 months. This frequently leads to poor patient compliance, which eventually leads to drug resistance, which worsens TB. According to WHO, roughly 600,000 new cases of rifampicin resistance, the most effective first-line treatment in 2017, of which around 490,000 developed MDR-TB globally.

According to the 2018 Global Report on Tuberculosis Vaccine, if effective efforts are not done by 2050, MDR-TB alone might cost the world US$ 16.7 trillion. Another issue with modern TB medications is drug toxicity as a result of high daily doses and prolonged treatment. Although the cost of tuberculosis drugs is not a major worry in developing nations because to government backing and free medicine, it is a concern in affluent countries such as the United States and Europe. Increased recognition of tuberculosis's lethality by multilateral organizations and national governments would boost funding for tuberculosis vaccine research. Increased R&D initiatives for the development of tuberculosis vaccines by firms and intergovernmental organizations are projected to drive the growth of the Tuberculosis Vaccine Market.

Comments

Post a Comment

Popular posts from this blog

Security Robot Market to Reach US$ 11.8 Billion by 2022

-
Image
Security Robot Market The Global Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period 2022 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Security robots are rapidly gaining traction due to their ability to enhance security and surveillance in various industries. These robots offer advantages such as round-the-clock monitoring, real-time video monitoring, and quick response to potential threats. The increasing need for advanced security measures to prevent theft, vandalism, and unauthorized access is driving the demand for security robots. These robots are widely used in industries such as retail, healthcare, transportation, and manufacturing to ensure the safety of assets and individuals. The market is expected to witness significant growth due to the rising security concerns and advancements in robotic technologies. Market Key Trends: One ke
Read more

Intravenous Fluid Therapy is the Fastest Growing Segment Fueling the Growth of Intravenous Solutions Market

-
Image
Intravenous Solutions Market The global Intravenous Solutions Market is estimated to be valued at US$ 577,228 bn or Million in 2023 and is expected to exhibit a CAGR of 6.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Intravenous solutions are fluids administered through a vein via a needle or catheter. They are often used to provide essential nutrients, medications, or fluids to patients. Common uses include rehydration, correcting electrolyte imbalances, and ensuring nutrition is delivered for patients who cannot eat or absorb nutrients through the digestive system. Market key trends: One of the major trends in the intravenous solutions market is the increasing use of intravenous fluid therapy. Intravenous fluid therapy involves the administration of aqueous solutions containing electrolytes, sugars, and medications through an intravenous catheter. It is widely used for rehydration, maintenance of f
Read more

Global Report on LED Driver Market for the Forecast Period 2023-2030

-
Image
LED Driver Market The LED Driver Market has been growing rapidly over the past few years, driven by the increasing demand for energy-efficient lighting solutions across residential, commercial, and industrial sectors. LED (light-emitting diode) lighting technology has several advantages over traditional lighting solutions such as incandescent and fluorescent lights, including longer lifespan, lower energy consumption, and lower maintenance costs. However, to power and control LED lights, an LED driver is required. The LED Driver Market was valued at USD 7.7 billion in 2020 and is expected to reach USD 10.5 billion by 2025, at a CAGR of 6.4% during the forecast period. LED drivers are electronic devices that regulate the power supply to LED lights. They convert AC voltage from a power source to DC voltage suitable for LEDs, and also provide the necessary current and voltage regulation to ensure proper functioning of the LED lights. LED drivers can be either constant current or constant
Read more